Science Explorer Back to mapMap
Discussion
Nonprofit · Springfield · United States

Cancer Research for the Ozarks

Research works
17
▼ 44% vs 2018-21
Citations
414
23.8 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
33%
world 40%
International
16%
world 18%

Not ranked overall: Cancer Research for the Ozarks is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cancer Research for the Ozarks work in?

In all years, 56% of research at Cancer Research for the Ozarks is in Health Sciences, 17% in Physical Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (8%), Environmental Science (8%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 56.2% of its workMedicine: 9 fractional works · 50.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 9.0% of its workOncology: 1 fractional works · 6.6% of its workPathology and Forensic Medicine: 1 fractional works · 6.5% of its workEmergency Medicine: 1 fractional works · 4.1% of its workReproductive Medicine: 1 fractional works · 4.0% of its workSurgery: 1 fractional works · 3.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.9% of its workEpidemiology: 0 fractional works · 2.6% of its workObstetrics and Gynecology: 0 fractional works · 2.0% of its workPhysiology: 0 fractional works · 2.0% of its workPharmacology: 0 fractional works · 1.7% of its workPsychiatry and Mental health: 0 fractional works · 1.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.9% of its workFamily Practice: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 4.5% of its workGeneral Health Professions: 0 fractional works · 2.5% of its workEmergency Medical Services: 0 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.6% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workIssues, ethics and legal aspects: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workPhysical Sciences: 3 fractional works · 16.8% of its workEnvironmental Science: 1 fractional works · 7.6% of its workEcology: 1 fractional works · 3.2% of its workWater Science and Technology: 0 fractional works · 1.9% of its workEnvironmental Chemistry: 0 fractional works · 1.3% of its workEnvironmental Engineering: 0 fractional works · 0.6% of its workGlobal and Planetary Change: 0 fractional works · 0.6% of its workEngineering: 1 fractional works · 4.0% of its workElectrical and Electronic Engineering: 0 fractional works · 2.9% of its workOcean Engineering: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 2.9% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 2.9% of its workEarth and Planetary Sciences: 0 fractional works · 1.9% of its workGeophysics: 0 fractional works · 1.9% of its workChemistry: 0 fractional works · 0.3% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.2% of its workLife Sciences: 2 fractional works · 13.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 7.9% of its workMolecular Biology: 1 fractional works · 5.1% of its workCancer Research: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 0.7% of its workAgricultural and Biological Sciences: 1 fractional works · 4.0% of its workInsect Science: 0 fractional works · 1.9% of its workPlant Science: 0 fractional works · 1.9% of its workAnimal Science and Zoology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 1.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.5% of its workSocial Sciences: 2 fractional works · 13.5% of its workArts and Humanities: 1 fractional works · 5.7% of its workConservation: 1 fractional works · 5.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 4.9% of its workEconomics and Econometrics: 1 fractional works · 4.9% of its workSocial Sciences: 0 fractional works · 1.9% of its workAnthropology: 0 fractional works · 1.9% of its workPsychology: 0 fractional works · 1.0% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.0% of its workALL ITS WORKCancer Researchfor the Ozarks17fractional works, all years
Life Sciences13%Physical Sciences17%Health Sciences56%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine950.7%
    2. Health Professions14.5%
    3. Nursing00.6%
    4. Veterinary00.4%
    1. Environmental Science17.6%
    2. Engineering14.0%
    3. Physics and Astronomy02.9%
    4. Earth and Planetary Sciences01.9%
    5. Chemistry00.3%
    6. Computer Science00.2%
    1. Biochemistry, Genetics and Molecular Biology17.9%
    2. Agricultural and Biological Sciences14.0%
    3. Neuroscience01.1%
    4. Immunology and Microbiology00.5%
    1. Arts and Humanities15.7%
    2. Economics, Econometrics and Finance14.9%
    3. Social Sciences01.9%
    4. Psychology01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.67× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.33× its world share, 0 worksImmunology and Micro…Computer Science: 0.20× its world share, 0 worksComputer ScienceEngineering: 0.10× its world share, 0 worksEngineeringHealth Professions: 2.37× its world share, 0 worksHealth ProfessionsMedicine: 3.50× its world share, 1 worksMedicineNursing: 11.91× its world share, 0 worksNursingEconomics, Econometrics and Finance: 2.92× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 11.9×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Nursing11.91×0 works
  2. Medicine3.50×1 works
  3. Economics, Econometrics and Finance2.92×0 works
  4. Health Professions2.37×0 works
  5. Immunology and Microbiology2.33×0 works
  6. Biochemistry, Genetics and Molecular Biology1.67×0 works
  7. Computer Science0.20×0 works
  8. Engineering0.10×0 works

Who are the top researchers at Cancer Research for the Ozarks?

Ranked on the quality score, Albert J. Bonebrake and Robert L. Carolla lead among researchers whose main affiliation is Cancer Research for the Ozarks.

  1. 1 Albert J. Bonebrake United States · #1,254,154 worldwide 828 citations · 26 works
  2. 2 Robert L. Carolla United States · #3,241,528 worldwide 348 citations · 24 works
All ranked researchers at Cancer Research for the Ozarks

What are the most cited papers from Cancer Research for the Ozarks?

The most cited paper from Cancer Research for the Ozarks is "Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy" (Huib A.M. Kerstjens, Michael Engel, Ronald Dahl et al., 2012), with 668 citations. Next come "A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study" (179) and "A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer" (148).

Most cited papers
#PaperReleasedCitations
1 Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy Huib A.M. Kerstjens, Michael Engel, Ronald Dahl et al. · New England Journal of Medicine Open access 2 Sep 2012 668
2 A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study John Wendall Goodwin, John Crowley, Harmon J. Eyre et al. · Journal of Neuro-Oncology 1993 179
3 A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer Carol A Aghajanian, Virginia L. Filiaci, Don Steven Dizon et al. · Gynecologic Oncology Open access 24 May 2018 148
4 GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients Jay W. Carlson, James T. Kauderer, Alan David Hutson et al. · Gynecologic Oncology Open access 16 Dec 2019 128
5 A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study Bradley J. Monk, James T. Kauderer, Katherine Marie Moxley et al. · Gynecologic Oncology Open access 8 Oct 2018 125
All 71 most cited papers, with filters and sorting

Which research topics does Cancer Research for the Ozarks publish most on?

By volume in 2022-now: Ovarian cancer diagnosis and treatment, Biochemical Analysis and Sensing Techniques, Nicotinic Acetylcholine Receptors Study and Smoking Behavior and Cessation.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  2. 2 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
  3. 3 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  4. 4 Smoking Behavior and Cessation Physiology 0 works
  5. 5 Medication Adherence and Compliance Family Practice 0 works
  6. 6 PARP inhibition in cancer therapy Oncology 0 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
  8. 8 Cancer Treatment and Pharmacology Oncology 0 works
  9. 9 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 0 works
  10. 10 Female Genital Mutilation/Cutting Issues Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.6%not open67.4%

World: 40% of research is openly available.

with international co-authors15.6%domestic only84.4%

World: 18% is written across borders.

How has Cancer Research for the Ozarks's research output changed?

Output in 2022-2025 was 44% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer Research for the Ozarks as a percentage of every work published that year, 0.0000090% in 2024.

still counting0.000050%0.00010%0.00015%Cancer Research for the Ozarks0.0000099% in 2025200020102020

Fractional works of Cancer Research for the Ozarks over all fractional works that year. How the balance of science has shifted.

Other research institutions in Springfield

All research institutions in Springfield

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cancer Research for the Ozarks. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.